Sector: MedicalDUSA Pharmaceuticals, Inc. (NASDAQ: DUSA)
Headlines
- DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009
Nov 06, 2009 03:27 PM | DUSA
- DUSA Pharmaceuticals Reports Third Quarter 2009 Corporate Highlights and Financial Results
Nov 06, 2009 06:30 AM | DUSA
- DUSA Pharmaceuticals, Inc.(R) Announces Third Quarter Financial Results and Corporate Highlights Conference Call
Nov 03, 2009 06:30 AM | DUSA
- DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan(R) Kerastick(R) Sales Units
Oct 28, 2009 06:30 AM | DUSA
- DUSA Pharmaceuticals Named to Deloitte's 2009 Technology Fast 500 List of Fastest Growing Companies in North America
Oct 21, 2009 06:30 AM | DUSA
- DUSA Pharmaceuticals to Present at the Maxim Group 3rd Annual Growth Conference
Sep 22, 2009 08:31 AM | DUSA
- DUSA Pharmaceuticals to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
Sep 02, 2009 08:30 AM | DUSA
- STREET MOVES: Two Friedman Billings Analysts Leave Firm
Feb 08, 2008 10:47 AM | AIS, BRL, CGPI, DUSA, ENDP, FBR
- AVI BioPharma Reports Third Quarter Financial Results and DUSA Pharmaceuticals Reports Third Quarter Corporate Highlights and Financial Results
Nov 07, 2005 10:01 AM | AVII, DUSA, GILD
- AVI BioPharma Reports Third Quarter Financial Results and DUSA Pharmaceuticals Reports Third Quarter Corporate Highlights and Financial Results
Nov 07, 2005 10:01 AM | AVII, DUSA, GILD
- DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results
Aug 11, 2009 06:56 AM | DUSA
- DUSA Pharmaceuticals, Inc.(R) Announces Second Quarter Financial Results and Corporate Highlights Conference Call
Aug 06, 2009 06:30 AM | DUSA
- DUSA Pharmaceuticals Reports First Quarter 2009 Corporate Highlights and Financial Results
May 12, 2009 06:54 AM | DUSA
- DUSA Initiates Clinical Trial of Levulan(R) PDT on High-Risk Solid Organ Transplant Recipients
May 11, 2009 06:30 AM | DUSA
- DUSA Pharmaceuticals, Inc. Announces First Quarter Financial Results and Corporate Highlights Conference Call
May 06, 2009 04:15 PM | DUSA
- DUSA Hits the Road With The Skin Cancer Foundation to Raise Awareness of Skin Cancer
May 05, 2009 06:30 AM | DUSA
- DUSA Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Corporate Highlights and Financial Results
Mar 11, 2009 06:51 AM | DUSA
- DUSA Pharmaceuticals, Inc.(R) to Host Fourth Quarter and Full Year 2008 Financial Results and Corporate Highlights Conference Call
Mar 06, 2009 08:31 AM | DUSA
- DUSA Pharmaceuticals to Present at the 11th Annual BIO CEO & Investor Conference
Feb 04, 2009 05:00 PM | DUSA
- DUSA Elects Alexander Casdin to Board of Directors
Jan 29, 2009 01:15 PM | DUSA
- Form 4 DUSA PHARMACEUTICALS For: Jun 30 Filed by: LESSER MARVIN E (10K)
Jul 01, 2009 11:08 AM
- Form 4 Casdin Alexander W. For: Jun 30 (10K)
Jul 01, 2009 11:04 AM
- Form 4 Flynn James E For: Jun 25 (10K)
Jun 26, 2009 05:38 PM
- Form 3 DUSA PHARMACEUTICALS For: Jun 09 Filed by: LESSER MARVIN E (10K)
Jun 11, 2009 10:50 AM
- Form 4 Todisco Michael For: May 29 (10K)
May 29, 2009 10:55 AM
- Form 4 ODell William F For: May 29 (10K)
May 29, 2009 10:55 AM
- Form 4 MARCUS STUART L For: May 29 (10K)
May 29, 2009 10:50 AM
- Form 4 Casdin Alexander W. For: May 18 (10K)
May 20, 2009 06:02 PM
- Form 4 Todisco Michael For: Mar 13 (10K)
Mar 17, 2009 12:07 PM
- Form 4 ODell William F For: Mar 13 (10K)
Mar 17, 2009 12:03 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
DUSA
|
Compare to S&P
|
| YTD |
54.29 %
|
27.69 %
|
| 4 Weeks |
14.09 %
|
12.85 %
|
| 12 Weeks |
40.87 %
|
32.81 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 33.33 %
|
|
EPS Growth in Last Year: 75.00 %
|
|
Sales Growth in Last Quarter: -0.50 %
|
|
Sales Growth in Last Quarter: 21.03 %
|
|
